Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (126)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Ellison, J. W.
Right arrow Articles by Chiong, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ellison, J. W.
Right arrow Articles by Chiong, W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, Vol 6, 1341-1347, Copyright © 1997 by Oxford University Press


ARTICLES

PHOG, a candidate gene for involvement in the short stature of Turner syndrome

JW Ellison, Z Wardak, MF Young, P Gehron Robey, M Laig-Webster and W Chiong
Department of Pediatrics, University of California, San Francisco 94143, USA. ellison@cgl.ucsf.edu

The abnormalities seen in Turner syndrome (monosomy X) presumably result from haploinsufficiency of certain genes on the X chromosome. Gene dosage considerations lead to the prediction that the culpable genes escape X inactivation and have functional homologs on the Y chromosome. Among the genes with these characteristics are those residing in the pseudoautosomal regions (PAR) of the sex chromosomes. A pseudoautosomal location for a dosage-sensitive locus involved in stature has been suggested based on the analyses of patients with deletions of a specific segment of the short arm PAR; hemizygosity for this putative locus probably also contributes to the short stature in Turner individuals. We have isolated a gene from the critical deleted region that encodes a novel homeodomain-containing transcription factor and is expressed at highest levels in osteogenic cells. We have named the gene PHOG, for pseudoautosomal homeobox-containing osteogenic gene. Its deletion in patients with short stature, the predicted altered dosage in 45,X individuals, along with the nature of the encoded protein and its expression pattern, make PHOG an attractive candidate for involvement in the short stature of Turner syndrome. We have also found that the mouse homolog of PHOG is autosomal, which may help to explain the lack of a growth abnormality in mice with monosomy X.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
L. Bottarelli, C. Azzoni, F. Necchi, C. Lagrasta, E. Tamburini, T. D'Adda, S. Pizzi, L. Sarli, G. Rindi, and C. Bordi
Sex Chromosome Alterations Associate with Tumor Progression in Sporadic Colorectal Carcinomas
Clin. Cancer Res., August 1, 2007; 13(15): 4365 - 4370.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
G. Rappold, W. F Blum, E. P Shavrikova, B. J Crowe, R. Roeth, C. A Quigley, J. L Ross, and B. Niesler
Genotypes and phenotypes in children with short stature: clinical indicators of SHOX haploinsufficiency
J. Med. Genet., May 1, 2007; 44(5): 306 - 313.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
N. Sabherwal, F. Bangs, R. Roth, B. Weiss, K. Jantz, E. Tiecke, G. K. Hinkel, C. Spaich, B. P. Hauffa, H. van der Kamp, et al.
Long-range conserved non-coding SHOX sequences regulate expression in developing chicken limb and are associated with short stature phenotypes in human patients
Hum. Mol. Genet., January 15, 2007; 16(2): 210 - 222.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
W. F. Blum, B. J. Crowe, C. A. Quigley, H. Jung, D. Cao, J. L. Ross, L. Braun, G. Rappold, and for the SHOX Study Group
Growth Hormone Is Effective in Treatment of Short Stature Associated with Short Stature Homeobox-Containing Gene Deficiency: Two-Year Results of a Randomized, Controlled, Multicenter Trial
J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 219 - 228.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
C Huber, M Rosilio, A Munnich, V Cormier-Daire, and the French SHOX GeNeSIS Module
High incidence of SHOX anomalies in individuals with short stature
J. Med. Genet., September 1, 2006; 43(9): 735 - 739.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Cobb, A. Dierich, Y. Huss-Garcia, and D. Duboule
A mouse model for human short-stature syndromes identifies Shox2 as an upstream regulator of Runx2 during long-bone development
PNAS, March 21, 2006; 103(12): 4511 - 4515.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
L. Yu, S. Gu, S. Alappat, Y. Song, M. Yan, X. Zhang, G. Zhang, Y. Jiang, Z. Zhang, Y. Zhang, et al.
Shox2-deficient mice exhibit a rare type of incomplete clefting of the secondary palate
Development, October 1, 2005; 132(19): 4397 - 4406.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Marchini, T. Marttila, A. Winter, S. Caldeira, I. Malanchi, R. J. Blaschke, B. Hacker, E. Rao, M. Karperien, J. M. Wit, et al.
The Short Stature Homeodomain Protein SHOX Induces Cellular Growth Arrest and Apoptosis and Is Expressed in Human Growth Plate Chondrocytes
J. Biol. Chem., August 27, 2004; 279(35): 37103 - 37114.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. J. F. Munns, H. R. Haase, L. M. Crowther, M. T. Hayes, R. Blaschke, G. Rappold, I. A. Glass, and J. A. Batch
Expression of SHOX in Human Fetal and Childhood Growth Plate
J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 4130 - 4135.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
N Sabherwal, R J Blaschke, A Marchini, D Heine-Suner, J Rosell, J Ferragut, W F Blum, and G Rappold
A novel point mutation A170P in the SHOX gene defines impaired nuclear translocation as a molecular cause for Leri-Weill dyschondrosteosis and Langer dysplasia
J. Med. Genet., June 1, 2004; 41(6): e83 - e83.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. J. Blaschke, C. Topfer, A. Marchini, H. Steinbeisser, J. W. G. Janssen, and G. A. Rappold
Transcriptional and Translational Regulation of the Leri-Weill and Turner Syndrome Homeobox Gene SHOX
J. Biol. Chem., November 28, 2003; 278(48): 47820 - 47826.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
J. L. Frias, M. L. Davenport, Committee on Genetics, and Section on Endocrinology
Health Supervision for Children With Turner Syndrome
Pediatrics, March 1, 2003; 111(3): 692 - 702.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
L Stuppia, G Calabrese, V Gatta, S Pintor, E Morizio, D Fantasia, P Guanciali Franchi, M M Rinaldi, G Scarano, D Concolino, et al.
SHOX mutations detected by FISH and direct sequencing in patients with short stature
J. Med. Genet., February 1, 2003; 40(2): e11 - 11.
[Full Text] [PDF]


Home page
J. Med. Genet.Home page
S F Flanagan, C F J Munns, M Hayes, B Williams, M Berry, D Vickers, E Rao, G A Rappold, J A Batch, V J Hyland, et al.
Prevalence of mutations in the short stature homeobox containing gene (SHOX) in Madelung deformity of childhood
J. Med. Genet., October 1, 2002; 39(10): 758 - 763.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. H. Gravholt, A. L. Lauridsen, K. Brixen, L. Mosekilde, L. Heickendorff, and J. S. Christiansen
Marked Disproportionality in Bone Size and Mineral, and Distinct Abnormalities in Bone Markers and Calcitropic Hormones in Adult Turner Syndrome: A Cross-Sectional Study
J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2798 - 2808.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. A. Quigley, B. J. Crowe, D. G. Anglin, and J. J. Chipman
Growth Hormone and Low Dose Estrogen in Turner Syndrome: Results of a United States Multi-Center Trial to Near-Final Height
J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2033 - 2041.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
M. Elsheikh, D. B. Dunger, G. S. Conway, and J. A. H. Wass
Turner's Syndrome in Adulthood
Endocr. Rev., February 1, 2002; 23(1): 120 - 140.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
E. Rao, R. J. Blaschke, A. Marchini, B. Niesler, M. Burnett, and G. A. Rappold
The Leri-Weill and Turner syndrome homeobox gene SHOX encodes a cell-type specific transcriptional activator
Hum. Mol. Genet., December 1, 2001; 10(26): 3083 - 3091.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
J. Perry, S. Palmer, A. Gabriel, and A. Ashworth
A Short Pseudoautosomal Region in Laboratory Mice
Genome Res., November 1, 2001; 11(11): 1826 - 1832.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
C. A Boucher, C. A Sargent, T. Ogata, and N. A Affara
Breakpoint analysis of Turner patients with partial Xp deletions: implications for the lymphoedema gene location
J. Med. Genet., September 1, 2001; 38(9): 591 - 598.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
S. P ROBERTSON, D. J SHEARS, P. OEI, R. M WINTER, P. J SCAMBLER, S. AFTIMOS, and R. SAVARIRAYAN
Homozygous deletion of SHOX in a mentally retarded male with Langer mesomelic dysplasia
J. Med. Genet., December 1, 2000; 37(12): 959 - 964.
[Full Text]


Home page
Hum Mol GenetHome page
M. Clement-Jones, S. Schiller, E. Rao, R. J. Blaschke, A. Zuniga, R. Zeller, S. C. Robson, G. Binder, I. Glass, T. Strachan, et al.
The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome
Hum. Mol. Genet., March 22, 2000; 9(5): 695 - 702.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Binder, C. P. Schwarze, and M. B. Ranke
Identification of Short Stature Caused by SHOX Defects and Therapeutic Effect of Recombinant Human Growth Hormone
J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 245 - 249.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
Growth-Promoting Strategies in Turner's Syndrome
J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4345 - 4348.
[Full Text]


Home page
J. Med. Genet.Home page
M. Tzancheva, R. Kaneva, P. Kumanov, G. Williams, and C. Tyler-Smith
Two male patients with ring Y: definition of an interval in Yq contributing to Turner syndrome
J. Med. Genet., July 1, 1999; 36(7): 549 - 553.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. J. Blaschke, A. P. Monaghan, S. Schiller, B. Schechinger, E. Rao, H. Padilla-Nash, T. Ried, and G. A. Rappold
SHOT, a SHOX-related homeobox gene, is implicated in craniofacial, brain, heart, and limb development
PNAS, March 3, 1998; 95(5): 2406 - 2411.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
R. J. Blaschke and G. A. Rappold
Man to Mouse---Lessons Learned from the Distal End of the Human X Chromosome
Genome Res., December 1, 1997; 7(12): 1114 - 1117.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.